According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

Biocon said that it has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialize its GLP-1 products for treating diabetes and chronic weight management, ...

Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...

The companies will deliver products for diabetes and weight control in specific nations across the Middle East.

Recent research easing suicidality concerns about GLP-1s and suggesting potential psychiatric benefit has led to a call for ...

The study will evaluate the safety, tolerability and pharmacokinetic characteristics of the company's exenatide implant.

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...

In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.